相关实验视频

Updated: Jul 2, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

HER2+晚期胃癌:当前状态和机遇 (综述)

Hui-Hui Hu¹, Sai-Qi Wang¹, Huichen Zhao²

¹Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Department of Oncology, Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.

International journal of oncology

|February 23, 2024

概括

人类表皮生长因子受体2 (HER2) 阳性胃癌 (GC) 由于耐药性而带来治疗挑战. 本综述总结了针对HER2向治疗的进展,以及针对高级GC的组合治疗.

科学领域:

医学瘤学医学瘤学
胃肠病学胃肠病学
免疫治疗是一种免疫疗法.

背景情况:

人类表皮生长因子受体2 (HER2) 阳性胃癌 (GC) 占GC病例的10-20%.
特拉斯图祖马布改善了HER2阳性晚期GC (AGC) 的结果,但药物耐药性是一个重大挑战.
对HER2表达的动态监测对于识别可能受益于向治疗的患者至关重要.

研究的目的:

审查目前针对 HER2 阳性高级 GC 的向治疗药物的研究进展.
要总结结合并治疗HER2阳性晚期GC的进展.
为抗HER2治疗的未来应用提供见解.

主要方法:

对先进的GC抗HER2疗法的临床前和临床研究的文献评论.
分析当前的治疗策略,包括组合免疫疗法.
研究新的方法,如仿真抗原受体T细胞免疫疗法和癌症疫苗.

主要成果:

一些抗HER2药物,包括trastuzumab,DS-8201和RC48,用于HER2阳性AGC.
与抗HER2药物的联合免疫疗法是当前的一线治疗方法.
新兴疗法显示出改善HER2-阳性AGC的临床结果的希望.

结论:

对新型抗HER2疗法和组合策略的持续研究至关重要.
基于HER2表达监测的个性化治疗方法至关重要.
未来的方向包括探索免疫疗法和癌症疫苗,以提高HER2阳性GC的疗效.

关键词:

先进的胃癌是什么?人类表皮生长因子受体2 免疫疗法免疫疗法有针对性的治疗.这就是Trastuzumab.

更多相关视频

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...